IRCT20111105008013N9CompletedPhase 2
Double-blinde placebo-controlled clinical trial of effect of Silybum marianum extract capsules on systemic lupus erythematosus patients
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 70
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 50 years (—)
- Sex
- All
Inclusion Criteria
- •having active lupus
Exclusion Criteria
- •cardiovascular diseases
- •using irrelevant drugs with lupus
Investigators
Similar Trials
Recruiting
Phase 3
Evaluation of the effect of Ivermectin in treatment of outpatients with COVID-19IRCT20111224008507N4Mazandaran University of Medical Sciences1,000
Recruiting
Phase 3
Evaluation of the effect of Ivermectin in treatment of patients admitted with COVID-19COVID-19 infection.COVID-19, virus identifiedU07.1IRCT20111224008507N5Mazandaran University of Medical Sciences1,000
Recruiting
Phase 2
Double-blind placebo-controlled clinical trial of thalidomide for chronic granulomatous disease-associated colitisJPRN-jRCT2031200236Kawai Toshinao8
Recruiting
Not Applicable
Double-blind placebo-controlled clinical trial of thalidomide for chronic granulomatous disease-associated colitisChronic granulomatous disease associated colitisJPRN-UMIN000029324ational Center for Child Heath and Development8
Completed
Phase 2
Frankincense effect on urinary disorders in multiple sclerosisMultiple sclerosis.Demyelinating diseases of the central nervous systemIRCT2015071023144N1Ahvaz Jundishapur University of Medical Sciences68